{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T04:40:03Z","timestamp":1777092003620,"version":"3.51.4"},"reference-count":132,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.gofs.2021.12.005","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T12:37:06Z","timestamp":1639485426000},"page":"107-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Indications des mastectomies de r\u00e9duction de risque en dehors du risque av\u00e9r\u00e9 de pr\u00e9disposition h\u00e9r\u00e9ditaire\u00a0: recommandations du Coll\u00e8ge national des gyn\u00e9cologues et obst\u00e9triciens fran\u00e7ais (CNGOF)"],"prefix":"10.1016","volume":"50","author":[{"given":"Carole","family":"Mathelin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Barranger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martine","family":"Boisserie-Lacroix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e9rard","family":"Boutet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susie","family":"Brousse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Chabbert-Buffet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emile","family":"Dara\u00ef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yann","family":"Delpech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"Duraes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Espi\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc","family":"Fornecker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Golfier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Grosclaude","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Sophie","family":"Hamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edith","family":"Kermarrec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Lavou\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Lodi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9lisabeth","family":"Luporsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine M.","family":"Maugard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9bastien","family":"Moli\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Yves","family":"Seror","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Taris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Uzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Vaysse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Fritel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2021.12.005_bib0665","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.breast.2019.03.011","article-title":"Current knowledge of risk reducing mastectomy: indications, techniques, results, benefits, harms","volume":"46","author":"Baildam","year":"2019","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib0670","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/SLA.0000000000001698","article-title":"Growing use of contralateral prophylactic mastectomy despite no improvement in long-term survival for invasive breast cancer","volume":"265","author":"Wong","year":"2017","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0675","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s10549-018-4824-9","article-title":"Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect","volume":"171","author":"Liede","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0680","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3917\/lcp.119.0046","article-title":"Du traumatisme de l\u2019ablation d\u2019un sein apr\u00e8s cancer \u00e0 la reconstruction r\u00e9paratrice\u00a0: une travers\u00e9e","volume":"119","author":"Brullmann","year":"2007","journal-title":"Carnet PSY"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib0685","first-page":"3","article-title":"[CNGOF Guidelines for clinical practice: revision of the methodology]","volume":"48","author":"Schmitz","year":"2020","journal-title":"Gynecol Obstet Fertil Senol"},{"key":"10.1016\/j.gofs.2021.12.005_bib0690","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejogrb.2016.02.017","article-title":"Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors\u00a0\u2013\u00a0short text","volume":"200","author":"Lavoue","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0695","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0700","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00428-001-0541-5","article-title":"Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications","volume":"440","author":"Bratthauer","year":"2002","journal-title":"Virchows Arch"},{"issue":"33","key":"10.1016\/j.gofs.2021.12.005_bib0705","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib0710","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-018-0967-1","article-title":"Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape","volume":"20","author":"Kader","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0715","doi-asserted-by":"crossref","first-page":"879","DOI":"10.5858\/133.6.879","article-title":"Flat ductal intraepithelial neoplasia of the breast: a review of diagnostic criteria, differential diagnoses, molecular-genetic findings, and clinical relevance - it is time to appreciate the Azzopardi concept!","volume":"133","author":"Moinfar","year":"2009","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.gofs.2021.12.005_bib0720","first-page":"i","article-title":"Problems in breast pathology","volume":"11","author":"Azzopardi","year":"1979","journal-title":"Major Probl Pathol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib0725","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/00313020802568097","article-title":"Update on atypical epithelial hyperplasia and ductal carcinoma in situ","volume":"41","author":"Simpson","year":"2009","journal-title":"Pathology"},{"issue":"11","key":"10.1016\/j.gofs.2021.12.005_bib0730","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.6004\/jnccn.2018.7099","article-title":"Diagnosis and management of high-risk breast lesions","volume":"16","author":"Thomas","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib0735","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u00a0\u2013\u00a0risk assessment and management options","volume":"372","author":"Hartmann","year":"2015","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.gofs.2021.12.005_bib0740","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/cncr.30644","article-title":"Breast cancer prevention strategies in lobular carcinoma in situ: a decision analysis","volume":"123","author":"Wong","year":"2017","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0745","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"issue":"5","key":"10.1016\/j.gofs.2021.12.005_bib0750","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<1024::AID-CNCR12>3.0.CO;2-4","article-title":"Lobular neoplasia. Long-term risk of breast cancer and relation to other factors","volume":"78","author":"Bodian","year":"1996","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0755","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1002\/bjs.11616","article-title":"Use of bilateral prophylactic nipple-sparing mastectomy in patients with high risk of breast cancer","volume":"107","author":"Valero","year":"2020","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0760","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/bjs5.50117","article-title":"Evolving indications and long-term oncological outcomes of risk-reducing bilateral nipple-sparing mastectomy","volume":"3","author":"Grobmyer","year":"2019","journal-title":"BJS Open"},{"key":"10.1016\/j.gofs.2021.12.005_bib0765","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2017.05.030","article-title":"Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy","volume":"82","author":"Xie","year":"2017","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.gofs.2021.12.005_bib0770","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/archinte.165.5.516","article-title":"A population-based study of bilateral prophylactic mastectomy efficacy in women at elevated risk for breast cancer in community practices","volume":"165","author":"Geiger","year":"2005","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0775","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jacr.2020.07.036","article-title":"Risk for upgrade to malignancy after breast core needle biopsy diagnosis of lobular neoplasia: a systematic review and meta-analysis","volume":"17","author":"Shehata","year":"2020","journal-title":"J Am Coll Radiol"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0780","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.jgyn.2015.09.033","article-title":"[Benign breast tumors: recommendations of Coll\u00e8ge National des Gyn\u00e9cologues Obst\u00e9triciens Fran\u00e7ais (CNGOF)\u00a0\u2013\u00a0Short text]","volume":"44","author":"Lavou\u00e9","year":"2015","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/j.gofs.2021.12.005_bib0785","series-title":"NCCN Clinical Practice Guidelines in Oncology. Breast Cancer Risk Reduction version 1.2021","year":"2021"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib0790","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1245\/s10434-020-09107-z","article-title":"Prospective multicenter study validate a prediction model for surgery uptake among women with atypical breast lesions","volume":"28","author":"Uzan","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.gofs.2021.12.005_bib0795","article-title":"Op\u00e9rer ou non une l\u00e9sion atypique du sein\u202f? Prise en compte de l\u2019anxi\u00e9t\u00e9 dans l\u2019aide \u00e0 la d\u00e9cision partag\u00e9e","author":"Favier","year":"2021","journal-title":"Gynecol Obstet Fertil Senol"},{"issue":"9132","key":"10.1016\/j.gofs.2021.12.005_bib0800","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0140-6736(98)03301-7","article-title":"Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists\u2019 Collaborative Group","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib0805","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0360-3016(03)00203-7","article-title":"Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: a population-based study","volume":"56","author":"Gao","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.gofs.2021.12.005_bib0810","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1200\/JCO.2010.32.7395","article-title":"Declining incidence of contralateral breast cancer in the United States from 1975 to 2006","volume":"29","author":"Nichols","year":"2011","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib0815","doi-asserted-by":"crossref","first-page":"R149","DOI":"10.1186\/bcr767","article-title":"Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome","volume":"6","author":"Arpino","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0820","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/j.seminoncol.2019.03.002","article-title":"Invasive lobular breast cancer: a review of pathogenesis, diagnosis, management, and future directions of early stage disease","volume":"46","author":"Thomas","year":"2019","journal-title":"Semin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0825","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10549-018-4846-3","article-title":"Mortality after contralateral breast cancer in Denmark","volume":"171","author":"Langballe","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"28","key":"10.1016\/j.gofs.2021.12.005_bib0830","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1200\/JCO.2011.39.3645","article-title":"Tumor stage affects risk and prognosis of contralateral breast cancer: results from a large Swedish-population-based study","volume":"30","author":"Vichapat","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0835","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10549-011-1618-8","article-title":"Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnoses","volume":"130","author":"Vichapat","year":"2011","journal-title":"Breast Cancer Res Treat"},{"issue":"33","key":"10.1016\/j.gofs.2021.12.005_bib0840","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1200\/JCO.2007.12.3141","article-title":"Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment","volume":"25","author":"Tuttle","year":"2007","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib0845","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jamasurg.2014.2895","article-title":"Nationwide trends in mastectomy for early-stage breast cancer","volume":"150","author":"Kummerow","year":"2015","journal-title":"JAMA Surg"},{"issue":"16","key":"10.1016\/j.gofs.2021.12.005_bib0850","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1200\/JCO.2010.29.4041","article-title":"Clinical management factors contribute to the decision for contralateral prophylactic mastectomy","volume":"29","author":"King","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0855","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2013.5689","article-title":"Social and clinical determinants of contralateral prophylactic mastectomy","volume":"149","author":"Hawley","year":"2014","journal-title":"JAMA Surg"},{"issue":"Suppl. 3","key":"10.1016\/j.gofs.2021.12.005_bib0860","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1245\/s10434-010-1259-x","article-title":"Increase in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancer","volume":"17","author":"Stucky","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0865","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1245\/s10434-009-0362-3","article-title":"Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy","volume":"16","author":"Sorbero","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.gofs.2021.12.005_bib0870","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1245\/s10434-012-2299-1","article-title":"Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients","volume":"19","author":"Chung","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0875","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-017-4324-3","article-title":"Meta-analysis of pre-operative magnetic resonance imaging (MRI) and surgical treatment for breast cancer","volume":"165","author":"Houssami","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"19","key":"10.1016\/j.gofs.2021.12.005_bib0880","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2005.10.080","article-title":"Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project","volume":"23","author":"Herrinton","year":"2005","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.gofs.2021.12.005_bib0885","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/cncr.32618","article-title":"Magnitude of reduction in risk of second contralateral breast cancer with bilateral mastectomy in patients with breast cancer: data from California, 1998 through 2015","volume":"126","author":"Kurian","year":"2020","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0890","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/jso.25221","article-title":"No survival improvement of contralateral prophylactic mastectomy among women with invasive lobular carcinoma","volume":"118","author":"Yu","year":"2018","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.gofs.2021.12.005_bib0895","first-page":"CD002748","article-title":"Risk-reducing mastectomy for the prevention of primary breast cancer","volume":"4","author":"Carbine","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0900","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/jnci\/djq018","article-title":"Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients","volume":"102","author":"Bedrosian","year":"2010","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0905","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1245\/s10434-010-1136-7","article-title":"Contralateral prophylactic mastectomy is associated with a survival advantage in high-risk women with a personal history of breast cancer","volume":"17","author":"Boughey","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"22","key":"10.1016\/j.gofs.2021.12.005_bib0910","doi-asserted-by":"crossref","first-page":"5637","DOI":"10.1002\/cncr.27574","article-title":"Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status","volume":"118","author":"Brewster","year":"2012","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib0915","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-014-3160-y","article-title":"Contralateral prophylactic mastectomy and its association with reduced mortality: evidence for selection bias","volume":"148","author":"Jatoi","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib0920","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s10549-009-0497-8","article-title":"Contralateral risk-reducing mastectomy in BRCA1 and BRCA2 mutation carriers and other high-risk women in the Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer (kConFab)","volume":"120","author":"Kiely","year":"2010","journal-title":"Breast Cancer Res Treat"},{"issue":"11","key":"10.1016\/j.gofs.2021.12.005_bib0925","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1245\/s10434-014-3930-0","article-title":"Survival analysis of contralateral prophylactic mastectomy: a question of selection bias","volume":"21","author":"Kruper","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.gofs.2021.12.005_bib0930","doi-asserted-by":"crossref","first-page":"3938","DOI":"10.1200\/JCO.2001.19.19.3938","article-title":"Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer","volume":"19","author":"McDonnell","year":"2001","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0935","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1245\/s10434-014-3956-3","article-title":"Contralateral prophylactic mastectomy provides no survival benefit in young women with estrogen receptor-negative breast cancer","volume":"21","author":"Pesce","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib0940","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.7314\/APJCP.2014.15.3.1155","article-title":"Improved long-term survival with contralateral prophylactic mastectomy among young women","volume":"15","author":"Zeichner","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0945","doi-asserted-by":"crossref","first-page":"e562","DOI":"10.3747\/co.25.4169","article-title":"Contralateral prophylactic mastectomy in young women with breast cancer: a population-based analysis of predictive factors and clinical impact","volume":"25","author":"Bouchard-Fortier","year":"2018","journal-title":"Curr Oncol"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib0950","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9610(00)00505-5","article-title":"Contralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancer","volume":"180","author":"Peralta","year":"2000","journal-title":"Am J Surg"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0955","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1245\/s10434-010-1091-3","article-title":"Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998\u20132007","volume":"17","author":"Yao","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0960","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1245\/s10434-017-5931-2","article-title":"Contralateral breast cancer risk in women with ductal carcinoma in situ: is it high enough to justify bilateral mastectomy?","volume":"24","author":"Miller","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"4 Supplement","key":"10.1016\/j.gofs.2021.12.005_bib0965","article-title":"Abstract P2-08-04: Bilateral mastectomy in ductal carcinoma in situ: 10-year analysis of national inpatient sample database","volume":"80","author":"Malapati","year":"2020","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib0970","first-page":"Cd011276","article-title":"Breast surgery for metastatic breast cancer","volume":"3","author":"Tosello","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0975","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1245\/s10434-018-6593-4","article-title":"Streamlining decision making in contralateral risk-reducing mastectomy: impact of PREDICT and BOADICEA computations","volume":"25","author":"de Silva","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib0980","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2014.10.008","article-title":"Beyond BRCA: new hereditary breast cancer susceptibility genes","volume":"41","author":"Economopoulou","year":"2015","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.gofs.2021.12.005_bib0985","series-title":"\u00a9 Oncog\u00e9n\u00e9tique en 2019\/consultations & laboratoires","author":"Institut national du cancer (INCa)","year":"2019"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib0990","first-page":"219","article-title":"[Identification and management of hereditary predisposition to cancer of the breast and the ovary (update 2004)]","volume":"91","author":"Eisinger","year":"2004","journal-title":"Bull Cancer"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib0995","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bulcan.2018.08.003","article-title":"[The French Genetic and Cancer Consortium guidelines for multigene panel analysis in hereditary breast and ovarian cancer predisposition]","volume":"105","author":"Moretta","year":"2018","journal-title":"Bull Cancer"},{"key":"10.1016\/j.gofs.2021.12.005_bib1000","series-title":"Femmes porteuses d\u2019une mutation de BRCA1 ou BRCA2\/D\u00e9tection pr\u00e9coce du cancer du sein et des annexes et strat\u00e9gies de r\u00e9duction du risque","author":"INCa","year":"2017"},{"issue":"8","key":"10.1016\/j.gofs.2021.12.005_bib1005","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/s41436-018-0406-9","article-title":"BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors","volume":"21","author":"Lee","year":"2019","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1010","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1470-2045(18)30902-1","article-title":"10-year performance of four models of breast cancer risk: a validation study","volume":"20","author":"Terry","year":"2019","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13058-021-01399-7","article-title":"Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry","volume":"23","author":"Pal Choudhury","year":"2021","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.gofs.2021.12.005_bib1020","series-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018. Volume 1\u00a0\u2013\u00a0Tumeurs solides","year":"2019"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib1025","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s10269-011-2074-4","article-title":"Femmes \u00e0 risque","volume":"13","author":"Cohen","year":"2011","journal-title":"Oncologie"},{"key":"10.1016\/j.gofs.2021.12.005_bib1030","series-title":"Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (CG164)","author":"National Institute for Heath and Care Excellence (NICE)","year":"2013"},{"key":"10.1016\/j.gofs.2021.12.005_bib1035","doi-asserted-by":"crossref","first-page":"g2756","DOI":"10.1136\/bmj.g2756","article-title":"Management of women at high risk of breast cancer","volume":"348","author":"Armstrong","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.gofs.2021.12.005_bib1040","series-title":"Genetic\/familial high-risk assessment: breast, ovarian and pancreatic (version 1.2022)","author":"National Comprehensive Cancer Network (NCCN)","year":"2021"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib1045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","article-title":"Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer","volume":"340","author":"Hartmann","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib1050","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/ejso.2002.1279","article-title":"Clinical experience of prophylactic mastectomy followed by immediate breast reconstruction in women at hereditary risk of breast cancer (HB(O)C) or a proven BRCA1 and BRCA2 germ-line mutation","volume":"28","author":"Contant","year":"2002","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10549-020-05582-w","article-title":"Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients","volume":"181","author":"Frasson","year":"2020","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib1060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diii.2017.01.001","article-title":"BI-RADS((R)) fifth edition: a summary of changes","volume":"98","author":"Spak","year":"2017","journal-title":"Diagn Interv Imaging"},{"issue":"10","key":"10.1016\/j.gofs.2021.12.005_bib1065","doi-asserted-by":"crossref","first-page":"dju255","DOI":"10.1093\/jnci\/dju255","article-title":"Prevalence of mammographically dense breasts in the United States","volume":"106","author":"Sprague","year":"2014","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"10.1016\/j.gofs.2021.12.005_bib1070","doi-asserted-by":"crossref","first-page":"e2011792","DOI":"10.1001\/jamanetworkopen.2020.11792","article-title":"Screening performance of digital breast tomosynthesis vs. digital mammography in community practice by patient age, screening round, and breast density","volume":"3","author":"Lowry","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib1075","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1158\/1055-9965.EPI-06-0034","article-title":"Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis","volume":"15","author":"McCormack","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"24","key":"10.1016\/j.gofs.2021.12.005_bib1080","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1002\/cncr.24638","article-title":"Mammographic density and the risk of breast cancer recurrence after breast-conserving surgery","volume":"115","author":"Cil","year":"2009","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1085","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12880-018-0303-3","article-title":"Screening mammography for second breast cancers in women with history of early-stage breast cancer: factors and causes associated with non-detection","volume":"19","author":"Yeom","year":"2019","journal-title":"BMC Med Imaging"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-018-4736-8","article-title":"Dose-dependent effect of mammographic breast density on the risk of contralateral breast cancer","volume":"170","author":"Chowdhury","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13058-018-0948-4","article-title":"The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study","volume":"20","author":"Knight","year":"2018","journal-title":"Breast Cancer Res"},{"issue":"22","key":"10.1016\/j.gofs.2021.12.005_bib1100","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1903986","article-title":"Supplemental MRI Screening for women with extremely dense breast tissue","volume":"381","author":"Bakker","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.gofs.2021.12.005_bib1105","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2020.0572","article-title":"Comparison of abbreviated breast MRI vs. digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening","volume":"323","author":"Comstock","year":"2020","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.gofs.2021.12.005_bib1110","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.crad.2015.02.017","article-title":"Background parenchymal enhancement on breast MRI and mammographic breast density: correlation with tumour characteristics","volume":"70","author":"Kim","year":"2015","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib1115","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/jmri.24495","article-title":"Does MRI breast \u201cdensity\u201d (degree of background enhancement) correlate with mammographic breast density?","volume":"40","author":"Hansen","year":"2014","journal-title":"J Magn Reson Imaging"},{"issue":"1 Pt 1","key":"10.1016\/j.gofs.2021.12.005_bib1120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0002-9378(97)80024-5","article-title":"Proliferation of breast epithelial cells in healthy women during the menstrual cycle","volume":"176","author":"S\u00f6derqvist","year":"1997","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib1125","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10549-018-4916-6","article-title":"Histopathologic characteristics of background parenchymal enhancement (BPE) on breast MRI","volume":"172","author":"Sung","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib1130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1148\/radiol.13121101","article-title":"Evaluation of the kinetic properties of background parenchymal enhancement throughout the phases of the menstrual cycle","volume":"268","author":"Amarosa","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1135","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1148\/radiology.203.1.9122382","article-title":"Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency","volume":"203","author":"Kuhl","year":"1997","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.gofs.2021.12.005_bib1140","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s001170050273","article-title":"[Effect of age and menstrual cycle on mammography and MR mammography]","volume":"37","author":"Muller-Schimpfle","year":"1997","journal-title":"Radiologe"},{"issue":"7","key":"10.1016\/j.gofs.2021.12.005_bib1145","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejrad.2011.04.059","article-title":"Should breast MRI be performed with adjustment for the phase in patients\u2019 menstrual cycle? Correlation between mammographic density, age, and background enhancement on breast MRI without adjusting for the phase in patients\u2019 menstrual cycle","volume":"81","author":"Uematsu","year":"2012","journal-title":"Eur J Radiol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2463\/mrms.2012-0022","article-title":"Effect of the menstrual cycle on background parenchymal enhancement in breast MR imaging","volume":"12","author":"Kajihara","year":"2013","journal-title":"Magn Reson Med Sci"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib1155","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11547-010-0513-4","article-title":"Correlation between breast density in mammography and background enhancement in MR mammography","volume":"115","author":"Cubuk","year":"2010","journal-title":"Radiol Med"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib1160","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.2214\/AJR.09.2657","article-title":"Optimal timing of breast MRI examinations for premenopausal women who do not have a normal menstrual cycle","volume":"193","author":"Ellis","year":"2009","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1165","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1148\/rg.341135034","article-title":"Background parenchymal enhancement at breast MR imaging: normal patterns, diagnostic challenges, and potential for false-positive and false-negative interpretation","volume":"34","author":"Giess","year":"2014","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.gofs.2021.12.005_bib1170","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2015142304","article-title":"Are qualitative assessments of background parenchymal enhancement, amount of fibroglandular tissue on MR images, and mammographic density associated with breast cancer risk?","volume":"276","author":"Dontchos","year":"2015","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1148\/radiol.11102156","article-title":"Background parenchymal enhancement at breast MR imaging and breast cancer risk","volume":"260","author":"King","year":"2011","journal-title":"Radiology"},{"issue":"12","key":"10.1016\/j.gofs.2021.12.005_bib1180","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1200\/JCO.18.00378","article-title":"Population-based assessment of the association between magnetic resonance imaging background parenchymal enhancement and future primary breast cancer risk","volume":"37","author":"Arasu","year":"2019","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.gofs.2021.12.005_bib1185","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1007\/s00330-019-06020-2","article-title":"Amount of fibroglandular tissue FGT and background parenchymal enhancement BPE in relation to breast cancer risk and false positives in a breast MRI screening program: a retrospective cohort study","volume":"29","author":"Vreemann","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib1190","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1148\/radiol.2019182441","article-title":"The association of background parenchymal enhancement at breast MRI with breast cancer: a systematic review and meta-analysis","volume":"292","author":"Thompson","year":"2019","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.gofs.2021.12.005_bib1195","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2214\/AJR.09.3568","article-title":"Breast cancers not detected at MRI: review of false-negative lesions","volume":"194","author":"Shimauchi","year":"2010","journal-title":"AJR Am J Roentgenol"},{"issue":"3","key":"10.1016\/j.gofs.2021.12.005_bib1200","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1148\/radiol.2243010547","article-title":"Undetected malignancies of the breast: dynamic contrast-enhanced MR imaging at 1.0T","volume":"224","author":"Teifke","year":"2002","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.gofs.2021.12.005_bib1205","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00330-011-2175-6","article-title":"Does the degree of background enhancement in breast MRI affect the detection and staging of breast cancer?","volume":"21","author":"Uematsu","year":"2011","journal-title":"Eur Radiol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1210","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2214\/AJR.10.4550","article-title":"Background parenchymal enhancement on baseline screening breast MRI: impact on biopsy rate and short-interval follow-up","volume":"196","author":"Hambly","year":"2011","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1215","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1148\/radiol.10101009","article-title":"Screening breast MR imaging: comparison of interpretation of baseline and annual follow-up studies","volume":"259","author":"Abramovici","year":"2011","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1220","doi-asserted-by":"crossref","first-page":"W373","DOI":"10.2214\/AJR.10.6272","article-title":"Background parenchymal enhancement on breast MRI: impact on diagnostic performance","volume":"198","author":"DeMartini","year":"2012","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1225","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14366\/usg.18002","article-title":"Additional lesions seen in magnetic resonance imaging of breast cancer patients: the role of second-look ultrasound and imaging-guided interventions","volume":"38","author":"Park","year":"2019","journal-title":"Ultrasonography"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1230","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/bcr3451","article-title":"Change of mammographic density predicts the risk of contralateral breast cancer\u00a0\u2013\u00a0a case-control study","volume":"15","author":"Sandberg","year":"2013","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1235","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s00330-020-07215-8","article-title":"Calcifications with suspicious morphology at mammography: should they all be considered with the same clinical significance?","volume":"31","author":"Choi","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.gofs.2021.12.005_bib1240","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ejrad.2016.11.022","article-title":"A matrix of morphology and distribution of calcifications in the breast: analysis of 849 vacuum-assisted biopsies","volume":"86","author":"Kaltenbach","year":"2017","journal-title":"Eur J Radiol"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1245","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S1278-3218(97)81497-7","article-title":"[Bilateral breast cancer after Hodgkin disease. Clinical and pathological characteristics and therapeutic possibilities: an analysis of 13 cases]","volume":"1","author":"Cutuli","year":"1997","journal-title":"Cancer Radiother"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1250","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijrobp.2008.04.068","article-title":"Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease","volume":"72","author":"Basu","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"19","key":"10.1016\/j.gofs.2021.12.005_bib1255","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/jnci\/dji290","article-title":"Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma","volume":"97","author":"Travis","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"21","key":"10.1016\/j.gofs.2021.12.005_bib1260","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2013.54.4601","article-title":"Breast cancer after chest radiation therapy for childhood cancer","volume":"32","author":"Moskowitz","year":"2014","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1265","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1470-2045(03)01033-7","article-title":"Breast cancer in women after treatment for Hodgkin's disease","volume":"4","author":"Deniz","year":"2003","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1270","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ijrobp.2008.03.066","article-title":"Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter","volume":"73","author":"Alm El-Din","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1275","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.290.4.465","article-title":"Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease","volume":"290","author":"Travis","year":"2003","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1280","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1200\/JCO.2000.18.4.765","article-title":"Management of breast cancer after Hodgkin's disease","volume":"18","author":"Wolden","year":"2000","journal-title":"J Clin Oncol"},{"issue":"18","key":"10.1016\/j.gofs.2021.12.005_bib1285","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1200\/JCO.2010.32.4079","article-title":"Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study","volume":"29","author":"Elkin","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1290","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnci\/85.1.25","article-title":"Breast cancer after treatment of Hodgkin's disease","volume":"85","author":"Hancock","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.gofs.2021.12.005_bib1295","series-title":"NCCN Clinical Practice Guidelines in Oncology. Hodgkin Lymphoma version 4.2021","year":"2021"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.10100991","article-title":"Screening breast MR imaging in women with a history of chest irradiation","volume":"259","author":"Sung","year":"2011","journal-title":"Radiology"},{"key":"10.1016\/j.gofs.2021.12.005_bib1305","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fgene.2016.00071","article-title":"Evaluation of BRCAPRO risk assessment model in patients with ductal carcinoma in situ who underwent clinical BRCA genetic testing","volume":"7","author":"Elsayegh","year":"2016","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib1310","doi-asserted-by":"crossref","first-page":"e03794","DOI":"10.1016\/j.heliyon.2020.e03794","article-title":"Assessment of the risk of developing breast cancer using the Gail model in Asian females: a systematic review","volume":"6","author":"Solikhah","year":"2020","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.gofs.2021.12.005_bib1315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1214\/19-STS729","article-title":"Risk models for breast cancer and their validation","volume":"35","author":"Brentnall","year":"2020","journal-title":"Stat Sci"},{"issue":"4","key":"10.1016\/j.gofs.2021.12.005_bib0660","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/jnci\/djz149","article-title":"Mammographic Density change and risk of breast cancer","volume":"112","author":"Azam","year":"2020","journal-title":"J Natl Cancer Inst"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 &amp; S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921003433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718921003433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:41:39Z","timestamp":1762854099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718921003433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":132,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2468718921003433"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2021.12.005","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indications des mastectomies de r\u00e9duction de risque en dehors du risque av\u00e9r\u00e9 de pr\u00e9disposition h\u00e9r\u00e9ditaire\u00a0: recommandations du Coll\u00e8ge national des gyn\u00e9cologues et obst\u00e9triciens fran\u00e7ais (CNGOF)","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2021.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}